Stomach cancer survival rates
Cancer survival rates are usually discussed in terms of 5-year relative survival, which means the proportion of patients who are alive five years after diagnosis. Keep in mind that statistics like these are based on large groups of people and cannot predict what might happen with an individual patient. In addition, the most current national data is from patients diagnosed between 2015 and 2019, which doesn’t reflect the impact of the latest treatment advances.
In the United States, overall survival (including all stages of disease) among people diagnosed with stomach cancer is 33.3%. The National Cancer Institute records survival rates using three very broad categories:
- Localized disease. In patients with early-stage, localized cancers where the cancer is confined to the primary site, 5-year survival is 71.8%.
- Regional disease. Among those whose cancer has spread to regional lymph nodes, the survival is 32.9%.
- Distant disease. Patients with stomach cancer that has metastasized to other body areas at the time of diagnosis, have a survival rate of 5.9%.
How Roswell Park optimizes your survival
As a national leader in cancer care, Roswell Park’s approach includes several components that maximize survival and quality of life, including:
- Minimally invasive surgery that is less traumatic to the body and speeds healing, allowing subsequent treatments such as chemotherapy to begin sooner.
- Access to the latest treatment advances. We are able to offer our patients more treatment options through clinical trials, offering these newest approaches years before they become available to other providers.
With evolving therapies in both surgical and medical options, gastric cancer treatment and outcomes are changing rapidly and at Roswell Park, we offer you the best treatment possible.